Silvia Kalantari

20PUBLICATIONS
113CO-AUTHORS
Molecular targetsNeural engineeringInfant and child healthNeurology and neuromuscular diseasesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 08, 2026
Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature review.

|Apr 14, 2026
The ZMIZ1-GTF2I interaction as a potential contributor to the neurodevelopmental phenotype in neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies (NEDDFSA).

Alberto De Rosa, Silvia Kalantari

|Feb 18, 2026
Expanding the Phenotype of TAB2-Related Syndrome: The First Case With Cleft Palate and Insights Into Palatal Development.

Alberto De Rosa, Silvia Kalantari, Marta Carboni

|Jul 29, 2025
Expanding the Phenotypic Spectrum Associated with DPH5-Related Diphthamide Deficiency.

Davide Politano, Cecilia Mancini, Massimiliano Celario

|Jul 24, 2025
'Knowing and Treating Kosaki/Penttinen syndrome' international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors.

Yordi-Michaël Bouhatous, Cecilie Bredrup, Agnes Maurer

|Jul 04, 2025
Pulmonary Arterial Hypertension Onset in an Adult Woman With a TBX4 Likely Pathogenic Variant Following Imatinib Administration: A Case Report.

Simone Carbonera, Laura Scelsi, Alessandra Greco

Pageof 4

Frequent Collaborators

3 joint publications

Fabio Sirchia

3 joint publications

Mridul Johari

3 joint publications

Alessandro Mussa

2 joint publications

Enza Maria Valente